Skip to content

Author

M. Ali

We have 2 of 14 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Molecular Modelling, Molecular Docking, Molecular Dynamic Simulations, MM-GBSA Study, and Pharmacokinetics Prediction of New Isatin-Sulfonamide Derivatives as Selective Carbonic Anhydrase CA IX Inhibitors

Hypoxia within solid tumors triggers upregulation of carbonic anhydrase IX (CA IX), a key enzyme that maintains pH homeostasis and supports tumor survival, invasion, and therapy resistance. Selective CA IX inhibition is considered a promising anticancer strategy, but current inhibitors often lack isoform selectivity. T...

M. Ali, M. Mahdi · 0 citations

Palestinian Medical and Pharmaceutical Journal Computational Design of Isatin–Sulfonamide Hybrids as Selective Carbonic Anhydrase XII Inhibitors with Anticancer Potential

Computational results present novel isatin-sulfonamide hybrids as promising candidates with moderate suggested selectivity, and predicted to be safe CA XII-inhibitor for further experimental development as an anticancer agent.

M. Ali, M. Mahdi · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.